|
15 April 2008, Tuesday
|
08.00 | Registration and refreshments
|
08.30 | Organiser’s welcome remarks
|
08.45 | Guest-of-honour address
Lim Hng Kiang
Minister
Ministry of Trade & Industry, Singapore
|
08.55 | Chairman’s welcome remarks
|
09.00 | Global keynote address and executive interview: The evolving biomedical science and industry
- Market trends and drivers of the biomedical industry and crystal balling future growth
- Emerging biomedical innocation from Asia and its impact
- The evolution of the global biotech capital market: Where and how does Asia fit into the equation
|
10.00 | Morning refreshments, BioMedical Technology Showcase session and combined speed networking
|
| IDENTIFYING THE CHALLENGES AND OPPORTUNITIES IN BIOINFORMATICS IN ASIA |
|
11.00 | Chairperson’s opening address
|
| | Professor Tan Tin Wee, Deputy Head, Biochemistry Department, NUS Focal Point for Bioinformatics, ASEAN Virtual Inst of Science & Technology
|
11.10 | Bioinformatics host country opening keynote: Examining the Bioinformatics industry in Singapore and its role in pharma and biotech industry moving forwards 2008- 2009
- The evolution and growth of the bioinformatics industry in Singapore
- The role of the BII and the part BII plays in supporting the development of pharma and biotech industry
- The challenges and opportunities in the future
|
| |
|
11.40 | Round table discussion on bioinformatics developments in their respective countries
- What are ASEAN initiatives put in place to encourage the sharing of biomedical information?
- What are some of the challenges faced in using bioinformatics?
- Individual country discussion
|
12.30 | Afternoon refreshment, showcase session and speed networking
|
| BRIDGING THE GAP BETWEEN LIFE SCIENCE & IT |
|
14.00 | Identification of master control genes for radioprotection and for protection against a broad-spectrum viral infection |
| | Dr Grace Wong, President & Chief Scientific Officer, ActoKine Therapeutics
|
14.30 | Designing next generation data architecture in preparation for the data challenges of bioinformatics implementation
- Developing a data architecture with time, space, financial and quality benefits
- Incorporating flexibility in your data architecture to cope with changing demands of operational business units
- Case study on KOBIC
|
| |
|
15.00 | Bio21: Molecular Medicine Informatics Model – A unique clinical research data linkage platform
- Developing a platform that provides researchers access to data from disparate exsisting database
- Successfully linking publicly available research and genetic profiling data
- Case study on Molecular Medicine Informatics Model
|
| |
|
15.30 | Afternoon refreshments and showcase session
|
| NEXT GENERATION BUSINESS MODELS & OUTSOURCING |
|
16.30 | Implementing IT solutions for Biomarkers in Bio-Pharmaceutical R&D
- The move to incorporate biomarker concepts throughout R&D and building significant molecular imaging capabilities
- What are the IT standards and architectures that support incorporation of imaging biomarkers into drug discovery and clinical development?
- Challenges related to integration of imaging biomarker data with clinical and genotypic data
|
| | Dr Michael Shi, Director, Biomarker Project Leader, Exploratory Oncology Department, Novartis
|
17.00 | Successfully utilizing bioinformatics, imaging and data sharing technologies in biomarker R&D
- Identifying new technologies for usage in biomarker R&D
- The role bioinformatics, imaging and data sharing can enhance biomarker research
- Case study on Actis Biologics
|
| |
|
17.30 | Close of conference day one
|
19.00 | BioMedical Industry Awards & Gala Dinner
|
|
16 April 2008, Wednesday
|
08.00 | Registration and refreshments
|
08.45 | Chairman's opening remarks
|
|
|
| SECURITY, STANDARDS AND INTEROPERABILITY ISSUES |
|
09.00 | Addressing recent security issues in pharmaceutical/bioinformatics data management
- Identifying the security concerns of integrating, transferring and managing huge data sets across regional centers
- Strategies to ensure and prevent breach of data security
- Case study on I2R
|
| |
|
09.30 | Interoperability & standards: Progressing towards an industry architecture in clinical research and translational medicine - The BRIDG Model
- Overview and explanation of the BRIDG Model
- Standards harmonization across biomedical/clinical research and healthcare
- Industry case studies for BRIDG implementation
|
| | Mr Bron Kisler, Director, Terminology and Strategic Alliance/ Co-Founder, BRIDG Model
|
10.00 | The importance of MHC binding and in silico prediction
- Overview of cell-mediated immune response and importance of MHC binding
- Use of state-of-the-art computational algorithms to model/predict MHC binding events
- Relevance to the design of vaccines and therapeutics
|
| | Dr Victor Tong, Prinicipal Investigator, Molecular Design Group, Infocomm Research Institute
|
10.30 | Morning refreshments and showcase session
|
11.00 | Effectively creating the IT infrastructure for enhanced data management in electronic health/medical records – Kameda Medical Centre
- Implementing innovative technologies that can help to improve the quality and reduce costs associated with computerizing records
- Creating a system that integrates data used by nearly 30 hospitals in Japan to assist in managing the workflow of patient care delivery at their facilities
- Case study on Kameda Medical Centre’s KAI system
|
| |
|
| SUCCESSFUL DATA INTEGRATION & TRANSFER |
|
11.30 | Addressing the need to develop an informatics system that integrate data systems in a clinical/university framework – Vienna General Hospital
- The implementation of General Hospital Information Management (Allgemeines Krankenhaus Information Management) AKIM project
- The ongoing implementation of a gene expression (micro-array chips) platform
- Discussion of the solutions envisaged to ensure flexibility, user-friendliness and modularity of the bioinformatics platform
|
| |
|
12.00 | Addressing the need to develop Electronic Data Capture as a cost effective integrated enterprise solution in clinical trials
- Developing a flexible Electronic Data Capture solution that will enhance speed and productivity gains of clinicial trials
- Successfully yielding maximum gains from your EDC
- Case study on Merck
|
| | Ms Julie Olszewski, Worldwide Clinical Data Management Operations, Regional Director Asia Pacific, Merck Sharp & Dohme
|
12.30 | Network luncheon
|
14.00 | Innovative Biotechnology Showcase by Invitrogen -
Vector NTI® software: a scalable solution for sequence data analysis and management
- To extract understanding from information, life scientists need effective solutions for data integration, visualization, management, and search
- To maximize productivity, research and IT directors need organizational data visibility, sharing, protection and storage
- See how Vector NTI® software meets these needs when analyzing and managing critical sequence data, in one integrated platform
|
| |
|
14.30 | Panel Discussion: Identifying the challenges faced in implementing successful data integration and transfer and the role of bioinformatics in meeting these challenges
- What are some of the challenges faced by organizations in data integration and transfer?
- How can these challenges be met in a cost efficient manner?
- The role of bioinformatics in helping to meet these challenges
|
| |
|
15.30 | Translational medicine: a bioinformatics perspective
- How to integrate and transfer genomic data from different ethnic groups in Asia
- How to centrally manage and share data through different data centres efficiently
- The various roles of bioinformatics from bench to bedside and from western countries to Oriental markets
|
| |
|
16.00 | Afternoon refreshments and showcase session
|
| INNOVATION AND TECHNOLOGICAL ADVANCEMENTS |
|
16.30 | Successfully developing informatics solutions to meet drug discovery needs
- Developing and utilising informatics tools to meet current chanllenges in drug discovery and development
- A framework based approach to develop informatics platforms to integrate multiple applications and data sources
|
| |
|
17.00 | Developing of enabling Informatics Technology in support of the development of drug candidates
- Developing an informatics systems that integrate the information supplied from materials management system, laboratory IMS, data archival system and data documentation system
- Determining how higher sample throughput has led to integration of various analytical and informatics solution
- Case study on Pfizer
|
| |
|
18.00 | Close of conference day 2
|
18.30 | Cocktail Party Finale at Singapore Flyer
|
